Antidrug Antibodies Have Minimal Impact on the Pharmacodynamic Profile and Clinical Efficacy of Alemtuzumab in RRMS Patients From the CARE-MS StudiesTjalf Ziemssen,Antonio Bertolotto,Samuel F. Hunter,Jan Lycke,Alan Jacobs,Luke Chung,Qifeng Yu,Isabel Firmino,Christopher LaGankeNEUROLOGY(2019)引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要